ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.9204
0.08%
Brent Oil
82.62
-0.30%
Bitcoin
62,608.18
0.44%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Fusion Antibodies Plc (FAB)

  7. Fusion Antibodies Plc (FAB) Noticias

FAB

Fusion Antibodies (FAB)

Fusion Antibodies Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:FAB
FechaHoraFuenteTítuloSímboloCompañía
02/05/202401:00RNS Non-RegulatoryFusion Antibodies PLC Investor presentationLSE:FABFusion Antibodies Plc
30/04/202413:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:FABFusion Antibodies Plc
30/04/202401:00RNS Regulatory NewsFusion Antibodies PLC Year-end trading statementLSE:FABFusion Antibodies Plc
16/04/202401:00RNS Regulatory NewsFusion Antibodies PLC Change of auditorLSE:FABFusion Antibodies Plc
15/04/202407:29Alliance NewsAlliance NewsFusion Antibodies inks commercial contract for OptiPhage libraryLSE:FABFusion Antibodies Plc
15/04/202401:00RNS Regulatory NewsFusion Antibodies PLC Contract to develop a bespoke OptiPhage libraryLSE:FABFusion Antibodies Plc
02/04/202408:34RNS Regulatory NewsFusion Antibodies PLC Block admission six monthly returnLSE:FABFusion Antibodies Plc
28/03/202412:00RNS Regulatory NewsFusion Antibodies PLC Total Voting RightsLSE:FABFusion Antibodies Plc
11/03/202410:04RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
05/03/202404:40RNS Regulatory NewsFusion Antibodies PLC Result of General Meeting and Total Voting RightsLSE:FABFusion Antibodies Plc
27/02/202408:18Alliance NewsAlliance NewsTRADING UPDATES: Sondrel wins USD23 million contractLSE:FABFusion Antibodies Plc
27/02/202401:00RNS Regulatory NewsFusion Antibodies PLC First purchase order under MSALSE:FABFusion Antibodies Plc
14/02/202405:27Alliance NewsAlliance NewsIN BRIEF: Fusion Antibodies raises GBP1.4 million via placingLSE:FABFusion Antibodies Plc
14/02/202401:15RNS Regulatory NewsFusion Antibodies PLC Grant of options and issue of shares to directorsLSE:FABFusion Antibodies Plc
14/02/202401:00RNS Regulatory NewsFusion Antibodies PLC Placing to raise £1,375,000LSE:FABFusion Antibodies Plc
06/02/202405:48Alliance NewsAlliance NewsFusion Antibodies strikes follow-on research and development projectLSE:FABFusion Antibodies Plc
06/02/202401:00RNS Regulatory NewsFusion Antibodies PLC Follow-on project award and R&D updateLSE:FABFusion Antibodies Plc
01/02/202406:00Alliance NewsAlliance NewsFusion Antibodies gets tax credit from UK HMRC for OptiMAL platformLSE:FABFusion Antibodies Plc
01/02/202401:00RNS Regulatory NewsFusion Antibodies PLC HMRC R&D tax creditLSE:FABFusion Antibodies Plc
04/12/202306:26UK RegulatoryFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
04/12/202304:22Alliance NewsAlliance NewsFusion Antibodies shares fall with revenue despite "positive" outlookLSE:FABFusion Antibodies Plc
04/12/202301:00UK RegulatoryFusion Antibodies PLC Half-year ReportLSE:FABFusion Antibodies Plc
28/11/202307:23Dow Jones NewsFusion Antibodies Shares Rise on US Cancer Institute CollaborationLSE:FABFusion Antibodies Plc
28/11/202306:09Alliance NewsAlliance NewsFusion Antibodies shares up on deal with US National Cancer InstituteLSE:FABFusion Antibodies Plc
28/11/202301:00UK RegulatoryFusion Antibodies PLC OptiMAL collaboration agreementLSE:FABFusion Antibodies Plc
09/11/202306:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Wincanton profit down; James Cropper ups payoutLSE:FABFusion Antibodies Plc
09/11/202301:00UK RegulatoryFusion Antibodies PLC Half year trading updateLSE:FABFusion Antibodies Plc
27/10/202305:57UK RegulatoryFusion Antibodies PLC Result of AGMLSE:FABFusion Antibodies Plc
29/09/202315:19Alliance NewsAlliance NewsEARNINGS: Tan Delta revenue jumps; Kendrick Resources loss widensLSE:FABFusion Antibodies Plc
29/09/202301:00UK RegulatoryFusion Antibodies PLC Final ResultsLSE:FABFusion Antibodies Plc
 Showing the most relevant articles for your search:LSE:FAB

Su Consulta Reciente

SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
CCOM
US500
US 500
AMEX
XLF
Financial Select Sector
FX
USDMXN
US Dollar vs MXN
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
FX
EURUSD
Euro vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
SOLUSD
Solana
NYSE
AXP
American Express
NYSE
NKE
Nike
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados